Shopify A

The ARK ETFs led by Cathie Woods sold 40,392 Shopify shares worth about $5.65 million, continuing to reduce the position. At the same time, ARK bought 96,201 shares of Intellia Therapeutics via the ARKG ETF worth about $1.22 million. Further rebalancing includes sales of AMD and Deere and purchases in the Solana staking ETF, underscoring a strategic shift toward biotech and crypto/blockchain. » More on de.investing.com

Sands Capital singled out Shopify as a detractor in Q2 after shares fell on investor concerns about rising AI expenses tied to Sidekick and guidance implying a sequential slowdown. The company reported 32% revenue growth, its fastest since 2021, with Sidekick usage up 400% and Campaigns up 300% year over year. Sands Capital says the AI costs are manageable and remains confident in Shopify's long-term growth driven by enterprise adoption, international expansion, higher take rates and AI-enabled product improvements. » More on finance.yahoo.com

Baron Fifth Avenue Growth Fund says Shopify's stock declined in Q2 mainly due to multiple compression rather than deteriorating business fundamentals, as P/E fell about 8.5%. Shopify posted robust GMV and revenue growth of roughly 30% year‑over‑year and the fund views the company as well positioned to benefit from AI-driven commerce given its merchant data and recent product launches. Analysts have trimmed price targets but continue to highlight Shopify's long‑term potential in AI commerce and expanding monetization opportunities. » More on finance.yahoo.com